Seraxis

Seraxis is a biotech company in Germantown, United States, founded in 2013. It has raised $47.0M across 4 rounds, most recently a $40.0M Series C in July 2025.

Employees
11–50
Founded
2013
Business Model
B2B
Total Funding
$47.0M
Last Round
$40.0M Series CJul 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 4 investors for this company. The full record is or through the API.

About

Seraxis develops pancreatic islet replacement therapies intended to treat insulin-requiring and type 1 diabetes. Its clinical candidate SR-02 uses replacement islets, while the company has also reported pancreatic organoids derived from its novel pancreas-derived stem cells and synthetic replacement endocrine clusters. The program has progressed through preclinical studies, GMP quality-system work, and FDA IND allowance for a clinical study of SR-02.

Summary

It lists 11–50 employees. It has raised $47.0M in total across 4 rounds, most recently a $40.0M Series C round in Jul 2025. Investors include Polaris Partners, Eli Lilly and Frazier Healthcare.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CJul 2025
$40.0M

Sign up to see all 4 events

Funding: Seed through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Seraxis on Indexed.vc
<a href="https://indexed.vc/companies/seraxis"><img src="https://indexed.vc/api/badge/company/seraxis" alt="Seraxis on Indexed.vc" width="260" height="76" /></a>